Related references
Note: Only part of the references are listed.Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders
Song-Yu Yang et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
Understanding Risk Factors for Alzheimer's Disease: Interplay of Neuroinflammation, Connexin-based Communication and Oxidative Stress
Rodrigo A. Quintanilla et al.
ARCHIVES OF MEDICAL RESEARCH (2012)
Diagnostic accuracy of blood and CSF lactate in identifying children with mitochondrial diseases affecting the central nervous system
Keitaro Yamada et al.
BRAIN & DEVELOPMENT (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration
Luka Kulic et al.
NEUROBIOLOGY OF AGING (2011)
Increased Levels of Soluble LR11 in Cerebrospinal Fluid of Patients with Alzheimer Disease
Takeshi Ikeuchi et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
A beta 1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: Indication of reversible A beta 1-42 aggregation?
Giulia M. Sancesario et al.
EXPERIMENTAL NEUROLOGY (2010)
CSF biomarkers predict a more malignant outcome in Alzheimer disease
A. K. Wallin et al.
NEUROLOGY (2010)
GLYCOGEN SYNTHASE KINASE-3β AND THE P25 ACTIVATOR OF CYCLIN DEPENDENT KINASE 5 INCREASE PAUSING OF MITOCHONDRIA IN NEURONS
M. Morel et al.
NEUROSCIENCE (2010)
Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease
Isidre Ferrer
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2009)
The Amino Terminus of Tau Inhibits Kinesin-Dependent Axonal Transport: Implications for Filament Toxicity
Nichole E. LaPointe et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice
S. Hauptmann et al.
NEUROBIOLOGY OF AGING (2009)
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
M. I. Kester et al.
NEUROLOGY (2009)
Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease
Jia Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease
Lisa Mosconi et al.
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease
Tanea Reed et al.
NEUROBIOLOGY OF DISEASE (2008)
Mitochondria in Neuroplasticity and Neurological Disorders
Mark P. Mattson et al.
NEURON (2008)
Mitochondrial dysfunction:: The first domino in brain aging and Alzheimer's disease?
Kristina Leuner et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Multiple-motor based transport and its regulation by Tau
Michael Vershinin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Involvement of oxidative stress in Alzheimer disease
Akihiko Nunomura et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons:: implications for free radical generation and oxidative damage in disease progression
M Manczak et al.
HUMAN MOLECULAR GENETICS (2006)
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards
Vladimir Hachinski et al.
STROKE (2006)
Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L Tau transgenic mice
DC David et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Ferulic acid ethyl ester protects neurons against amyloid β-peptide(1-42)-induced oxidative stress and neurotoxicity:: relationship to antioxidant activity
R Sultana et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease
ZZ Chong et al.
PROGRESS IN NEUROBIOLOGY (2005)
Role of tau phosphorylation by glycogen synthase kinase-3β in the regulation of organelle transport
Y Tatebayashi et al.
JOURNAL OF CELL SCIENCE (2004)
Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease - Implications for early mitochonrial dysfunction and oxidative damage
M Manczak et al.
NEUROMOLECULAR MEDICINE (2004)
Tau filament formation in transgenic mice expressing P301L tau
J Götz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia
L Parnetti et al.
NEUROLOGY (2000)
Share Paper
